Literature DB >> 31128357

Big data analysis of associations between patient reported outcomes, observer reported toxicities, and overall quality of life in head and neck cancer patients treated with radiation therapy.

Joel R Wilkie1, Michelle L Mierzwa2, John Yao2, Avraham Eisbruch2, Mary Feng3, Grant Weyburne2, Xiaoping Chen2, Lynn Holevinski2, Charles S Mayo2.   

Abstract

PURPOSE: To assess associations between a variety of patient-reported outcomes (PROs), observer reported toxicities (ORTs), and patient-reported overall quality of life (QOL) for head and neck cancer patients treated with radiotherapy, in order to identify important items for inclusion in prospective patient reporting in the clinic.
METHODS: 612 patients completed 27 PRO items from three questionnaires at 1273 follow-up visits, and clinicians provided ORTs according to CTCAE criteria. Using a big data approach, we measured associations among all PROs, between all PROs and ORTs, and between PROs/ORTs and QOL with Pearson (ρ) and Kendall (τ) correlation coefficients, and a novel analysis method based on receiver operating characteristic (ROC) curves used to detect thresholds in response levels demonstrating strong interactions.
RESULTS: PROs most strongly associated with QOL were recreation/entertainment, activity, and fatigue, with ρ = 0.51-0.60. Several PROs assessing a common functional outcome (eg. xerostomia) were highly associated with each other (PRO-PRO), with maximum ρ = 0.84. Maximum ORT-PRO correlations were ρ = 0.61 (dysgeusia versus taste), and ρ = 0.5 for ORT-QOL (dry mouth - day). The ROC method identified response thresholds with high area under the curve (AUC) scores for many ORT-PRO associations with maximum AUCavg = 0.78.
CONCLUSIONS: PRO associations identified activity, lifestyle and fatigue as items for strong consideration for inclusion in questionnaires in the clinic, and suggest that outcome information can be captured in fewer items than the 27 in this study. The ability of clinicians to assess patient toxicities is highest with more severe toxicities, underscoring the need for PRO collection in patient visits to understand and address patient symptoms.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Big data; Patient reported outcomes; Quality of life

Mesh:

Year:  2019        PMID: 31128357     DOI: 10.1016/j.radonc.2019.04.030

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  8 in total

1.  Fatigue in Patients With Head and Neck Cancer Treated With Radiation Therapy: A Prospective Study of Patient-Reported Outcomes and Their Association With Radiation Dose to the Cerebellum.

Authors:  Edvard Abel; Ewa Silander; Fredrik Nordström; Caroline Olsson; N Patrik Brodin; Jan Nyman; Thomas Björk-Eriksson; Eva Hammerlid
Journal:  Adv Radiat Oncol       Date:  2022-04-08

2.  Predicting late radiation-induced xerostomia with parotid gland PET biomarkers and dose metrics.

Authors:  Joel R Wilkie; Michelle L Mierzwa; Keith A Casper; Charles S Mayo; Matthew J Schipper; Avraham Eisbruch; Francis P Worden; Issam El Naqa; Benjamin L Viglianti; Benjamin S Rosen
Journal:  Radiother Oncol       Date:  2020-04-06       Impact factor: 6.280

3.  Effects of a Multidisciplinary Residential Nutritional Rehabilitation Program in Head and Neck Cancer Survivors-Results from the NUTRI-HAB Randomized Controlled Trial.

Authors:  Marianne Boll Kristensen; Irene Wessel; Anne Marie Beck; Karin B Dieperink; Tina Broby Mikkelsen; Jens-Jakob Kjer Møller; Ann-Dorthe Zwisler
Journal:  Nutrients       Date:  2020-07-17       Impact factor: 5.717

4.  Evaluation of a Nurse-led Aftercare Intervention for Patients With Head and Neck Cancer Treated With Radiotherapy and Cisplatin or Cetuximab.

Authors:  Cora Braat; Gerda M Verduijn; Heleen A van der Stege; Marinella P J Offerman; Mariëlle A C Peeters; AnneLoes van Staa; Wendy H Oldenmenger
Journal:  Cancer Nurs       Date:  2022 Mar-Apr 01       Impact factor: 2.760

5.  Assessing concordance between patient-reported and investigator-reported CTCAE after proton beam therapy for prostate cancer.

Authors:  Roman O Kowalchuk; David Hillman; Thomas B Daniels; Carlos E Vargas; Jean-Claude M Rwigema; William W Wong; Bradley J Stish; Amylou C Dueck; Richard Choo
Journal:  Clin Transl Radiat Oncol       Date:  2021-09-15

6.  Psychometric properties of patient-reported outcome measures for dysphagia in head and neck cancer: a systematic review protocol using COSMIN methodology.

Authors:  Beatrice Manduchi; Zhiyao Che; Margaret I Fitch; Jolie Ringash; Doris Howell; Rosemary Martino
Journal:  Syst Rev       Date:  2022-02-15

7.  Patient-reported outcomes and complications during head and neck cancer radiotherapy before versus during the COVID-19 pandemic.

Authors:  Sarah Nicole Hamilton; Nicole Chau; Eric Berthelet; Jonn Wu; Eric Tran; Melanie Chevrier; Victoria Lau; Matthew Chan; Kimberly DeVries; Vincent LaPointe; Robert A Olson
Journal:  Support Care Cancer       Date:  2021-11-26       Impact factor: 3.603

8.  Rationale and design of a randomised controlled trial investigating the effect of multidisciplinary nutritional rehabilitation for patients treated for head and neck cancer (the NUTRI-HAB trial).

Authors:  Marianne Boll Kristensen; Irene Wessel; Anne Marie Beck; Karin B Dieperink; Tina Broby Mikkelsen; Jens-Jakob Kjer Møller; Ann-Dorthe Zwisler
Journal:  Nutr J       Date:  2020-03-17       Impact factor: 3.271

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.